Gilead Sciences and LEO Pharma have entered a strategic collaboration to expedite the development and commercialisation of ...

Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/97.CLtJoeWu.js ...

Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 ...

Gilead Sciences Inc. and LEO Pharma have partnered to accelerate the development and commercialization of LEO Pharma’s small ...

Gilead Sciences and Danish dermatology specialist LEO Pharma announced a strategic partnership, marking another move outside ...

Gilead licenses Leo Pharma's oral STAT6 portfolio for inflammatory diseases in $250M upfront deal, potentially worth $1.7B, ...

Michel Forest to succeed David Wendling as Chief Technology OfficerAsit Tandon joins as Chief Network and Information Officer OTTAWA, Ontario, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Telesat (NASDAQ and TSX ...

The exosome therapies market is expected to experience significant growth due to increased interest in regenerative medicine, ...

The Cebu provincial government is preparing four initial cases against the National Museum of the Philippines (NMP) for still not returning the four pulpit panels to the Archdiocesan Shrine of ...

To date, Comcast has increased its dividend for 17 consecutive years, with a 10-year dividend growth rate of 10.9%. Read more ...

The exosome therapies market is expected to experience significant growth due to increased interest in regenerative medicine, cancer treatments, and drug delivery systems. Leading Indications ...

India News Live: Stay informed with our live blog covering India’s latest in politics, economy, crime, and general news. Get real-time updates on political developments, financial trends, crime ...